Hyperpolarized MRI aims to slash time needed to determine tumor treatment response

A new MRI technique being studied at Memorial Sloan Kettering Cancer Center in New York City could cut the time needed to reveal whether a tumor is responding to treatment from a matter of weeks to just a few days.
The technology in question makes use of hyperpolarized MRI to track tumors as they metabolize a sugar solution.

Read more here

Meaningful Use Not Necessarily Associated With Quality Improvement

Although one of the main goals of the Meaningful Use program is to improve the quality of care, there appears to be “no association” between being a “meaningful user” of electronic health records and the quality of care provided to patients, according to a new study published in JAMA Internal Medicine.

Read more here.

Hospital CEO Turnover Brings Fresh Perspective, Evolving Leadership Position

In an innovative and dynamic period for the healthcare industry, high CEO turnover, leaders from outside the traditional realm and C-suite changes bring new skills and fresh blood into hospitals and healthcare systems, according to a Hospitals & Health Networks post by Mary Grayson.

Read more here.

SPECT Less Costly Than PET, CTA

For the evaluation of patients with suspected CAD, the costs of single-photo emission CT were significantly lower than that of PET or coronary CTA, according to new data from the SPARC registry.  At 2 years, patients who underwent PET had higher costs and mortality compared with SPECT, and patients who underwent coronary CTA had higher costs and similar mortality compared with SPECT, researchers reported.

Read more here.

Page 1 of 912345...Last »